Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Mouth Neoplasms 1Lichen Planus, Oral 1Leukoplakia, Oral 1Carcinoma in Situ 1Brain Neoplasms 1

Interventions

Paclitaxel 2Carboplatin 2pembrolizumab 1iso-sulfan blue 1camrelizumab 1Watchful Waiting 1Taxes 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Adjuvant 1Positron Emission Tomography Computed Tomography 1Observation 1Nivolumab 1Magnetic Resonance Spectroscopy 1Immune Checkpoint Inhibitors 1Chemoradiotherapy 1Cetuximab 1Capecitabine 1Biopsy 1Aminolevulinic Acid 1(225)Ac-DOTA-c(RGDyK) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Mouth Neoplasms × Aminolevulinic Acid × Clear all
NCT06876038 2026-03-19

Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions

University of Massachusetts, Boston

Phase 2 Not yet recruiting
65 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma in Situ, Leukoplakia, Oral, Mouth Neoplasms, Lichen Planus, Oral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡